0001213900-24-004999.txt : 20240119 0001213900-24-004999.hdr.sgml : 20240119 20240119193938 ACCESSION NUMBER: 0001213900-24-004999 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240118 FILED AS OF DATE: 20240119 DATE AS OF CHANGE: 20240119 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Szot Matthew K CENTRAL INDEX KEY: 0001401385 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41596 FILM NUMBER: 24546833 MAIL ADDRESS: STREET 1: 802 NORTH DOUTY STREET CITY: HANFORD STATE: CA ZIP: 93230 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cadrenal Therapeutics, Inc. CENTRAL INDEX KEY: 0001937993 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 880860746 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 822 A1A NORTH STREET 2: SUITE 300 CITY: PONTE VEDRA STATE: FL ZIP: 32082 BUSINESS PHONE: 904-300-0701 MAIL ADDRESS: STREET 1: 822 A1A NORTH STREET 2: SUITE 300 CITY: PONTE VEDRA STATE: FL ZIP: 32082 4 1 ownership.xml OWNERSHIP DOCUMENT X0508 4 2024-01-18 0 0001937993 Cadrenal Therapeutics, Inc. CVKD 0001401385 Szot Matthew K C/O CADRENAL THERAPEUTICS, INC. 822 A1A NORTH, SUITE 306 PONTE VEDRA, FL 32082 0 1 0 0 Chief Financial Officer 0 Stock Options 0.94 2024-01-18 4 A 0 250000 0 A 2034-01-17 Common Stock 250000 250000 D These options vest 25% on February 1, 2025 and thereafter pro rata on a monthly basis for the next 36 months. /s/ Matthew K. Szot 2024-01-19